Anti-MAGE-C2 Antibody

Raised in rabbit and affinity-purified by epitope-specific immunogen chromatography, this polyclonal IgG reagent from Antibodies.com is supplied as an unconjugated antiserum preparation formulated in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The 50 µl vial is presented at a working concentration of 1 mg/ml and is intended for the detection of endogenous MAGE-C2 protein in human samples. Validation data published on the supplier page supports two routine immunoassay workflows, namely Western blotting (WB) and enzyme-linked immunosorbent assay (ELISA), making the antibody suitable for both qualitative expression screening and quantitative titre measurements against the MAGEC2 target. The immunogen was a synthetic peptide derived from the internal region of human MAGE-C2, which underpins the polyclonal recognition profile and broad epitope coverage characteristic of rabbit-hosted preparations. Researchers are advised to store the liquid formulation at -20 °C, where it remains stable for up to one year of continuous use without appreciable loss of titre; for shorter term bench work, aliquoting is recommended to minimise repeated freeze-thaw cycles. As a research-use-only reagent, the antibody is not validated or intended for diagnostic or therapeutic applications, and standard laboratory precautions for azide-containing buffers should be observed during handling. With its human reactivity, unconjugated format, and compatibility with both WB and ELISA platforms, this Antibodies.com product offers a flexible tool for laboratories investigating MAGE-C2 expression in cancer immunology, tumour-associated antigen profiling and related cell biology studies.